Xue Sheng

Intrinsic PD‐L1 promotes antitumor activity of CD8+ cytotoxic T lymphocytes via in cis interaction with CD80

Chunyang Li, Chunhong Ma, Chaojia Chen, 2022, Cancer communications.

Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity

Xuetian Yue, Zhuanchang Wu, Jie Zhang, 2024, Advanced science.

Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models

P. Zhan, Xinyong Liu, Xuetian Yue, 2023, Science Translational Medicine.